An Extension Trial to Evaluate Long-term Safety of SABER™-Bupivacaine for Pain Following Shoulder Surgery

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Pain
Trial Locations (8)

2145

Westmead

3135

Ringwood East

3220

Geelong

4066

Auchenflower

5000

Adelaide

5065

Toorak Gardens

8014

Christchurch

Unknown

Hamilton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Nycomed

INDUSTRY

collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Durect

INDUSTRY